TheraRadar
← Back
Data updated: Mar 29, 2026

OCULAR THERAPEUTIX

OphthalmologyCardiovascular
Pharma

OCULAR THERAPEUTIX is a pharmaceutical company focused on Ophthalmology, Cardiovascular. Key products include DEXTENZA.

2018
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

DEXTENZA
dexamethasone
3 indications · 2018

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DEXTENZA 2025-04-07
Efficacy
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Ophthalmology 78%
1 drugs Phase 3: 5 Phase 2: 4 Phase 1: 4
Cardiovascular 22%
0 drugs Phase 3: 2 Phase 2: 1 Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular, Ophthalmology
Baxter specialty
Cardiovascular, Ophthalmology
Bayer big-pharma
Cardiovascular, Ophthalmology
B BRAUN specialty
Ophthalmology, Cardiovascular
BAUSCH specialty
Ophthalmology, Cardiovascular